Arnie Oronsky

Dr. Arnie Oronsky has been with InterWest's life sciences team since 1994.

He is a board member of Amplimmune, Applied Genetic Technologies Corporation (AGTC), Arcion, Drais Pharmaceuticals, Dynavax Technologies (DVAX), Integrated Diagnostics, MacroGenics, RadioRX, TESARO and USDS.

As a Ph.D. in immunology and senior lecturer at the Department of Medicine at Johns Hopkins Medical School, Arnie brings a deep understanding of medical research to finding and investing in successful life sciences companies.

Prior to joining InterWest, Arnie was vice president for discovery research of the Lederle Laboratories division of American Cyanamid Company where he directed the research for new drugs.

Arnie received a Ph.D. in immunology from Columbia University and has published more than 125 articles in scientific journals.

Arnie Oronsky is the Managing Director at InterWest Partners, based in United States, North America. With a background in Venture Capital, Arnie Oronsky has a rich history of leadership and innovation. Arnie Oronsky studied Ph.D Immunology @ Columbia University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.